58 results
6-K
EX-99.3
REPCF
Replicel Life Sciences Inc.
18 Aug 21
RepliCel Life Sciences Announces Closing of Debt Settlement
12:34pm
NEWS RELEASE
RepliCel Adds Independent Director
Board of Director’s Strengthens Its Independence Oversight and Updates its Stock Options
VANCOUVER
6-K
EX-99.5
REPCF
Replicel Life Sciences Inc.
18 Aug 21
Current report (foreign)
12:20pm
clinical sites, obtaining all necessary approvals from institutional research boards (IRBs), oversight committees, and the Ministry of Health, Labour
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
28 Jul 22
Current report (foreign)
2:52pm
organization), as Chair of FIRM’s Specific Process Cells Committee intended to bring increased rigor and industry oversight to the development, manufacture
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
by Mr. Ma.
Oversight and Description of Director and NEO Compensation
Compensation Process
The Company appointed a Nominating, Compensation … is a standing committee of the Board. The role of the Audit Committee is to:
(a) assist the Board in its oversight responsibilities by reviewing: (i
6-K
REPCF
Replicel Life Sciences Inc.
30 Apr 08
Current report (foreign)
12:00am
conducted our audits in accordance with Canadian generally accepted auditing standards and the standards of the Public Company Accounting Oversight Board …
COMMENTS BY AUDITORS ON CANADA – UNITED STATES REPORTING DIFFERENCES
The standards of the Public Company Accounting Oversight Board (United States
6-K
EX-99.1
d9a9iw61e7xb c6sv5
16 Nov 21
RepliCel’s Clinical Advisory Team Delivers Skin Rejuvenation Clinical Study Synopsis to its Japanese Regulatory and Clinical Study Management Team
4:03pm
6-K
EX-99.1
jfvwft5zh0lf5gql
22 Jan 19
Current report (foreign)
4:43pm
6-K
EX-99.1
u36z0n jt
18 Nov 21
Notice of Annual General and Special Meeting of Shareholders
10:36am
6-K
33ohwhpcujy juap4rez
4 Jun 09
Current report (foreign)
12:00am
6-K
f00ydpblviz0 zyk8co
14 Oct 04
Current report (foreign)
12:00am
6-K
766zy07xhv2ch
11 Jul 05
Current report (foreign)
12:00am
6-K
d8l xreges8iw
4 May 10
Current report (foreign)
12:00am
6-K
ekv26l4 3i79oo86d
7 Jun 07
Current report (foreign)
12:00am
6-K
hxoqah
21 Sep 06
Current report (foreign)
12:00am
6-K
EX-99.1
6o7175
7 Jul 22
Statement of Executive Compensation
1:43pm
6-K
EX-99.1
apq3xuwlq4c30t1ajee8
30 Jun 22
Statement of Executive Compensation
11:16am
6-K
w7oq3zp1eyypo6 ue
15 Oct 09
Current report (foreign)
12:00am
6-K
EX-99.1
41ruxq2 ujunmasmfb4
9 Aug 23
Statement of Executive Compensation
7:41pm
6-K
EX-99.2
cxejm4hl8 67a32sot
30 Aug 23
Notice of Annual General and Special Meeting of Shareholders
5:15pm